TY - JOUR
T1 - Temporal trends in the utilization of advanced therapies among patients with acute pulmonary embolism
T2 - insights from a national database
AU - Abumoawad, Abdelrhman
AU - Shatla, Islam
AU - Behrooz, Leili
AU - Eberhardt, Robert T.
AU - Hamburg, Naomi
AU - Sedhom, Rami
AU - Elgendy, Islam Y.
AU - Kumbhani, Dharam J.
AU - Cameron, Scott J.
AU - Elbadawi, Ayman
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - There is a paucity of data regarding the contemporary temporal trends in the adoption of advanced pulmonary embolism (PE) therapies in the United States as well as the parallel trends in outcomes of patients with acute PE. Therefore, we queried the Nationwide Readmissions Database (years 2016-2020) to report the temporal trends in utilization of advanced PE therapies. Our final analysis included 920 770 hospitalizations with acute PE. We demonstrated an increase in the proportion of patients diagnosed with high-risk PE during the study years. Overall, there was an increase in the use of advanced PE therapies, which was mainly due to the increase in the utilization of systemic thrombolytics, and catheter-directed therapies. Also, extracorporeal membrane oxygenation cannulation showed an incremental increase over the study years. The use of inferior vena cava filter has declined, while the use of surgical embolectomy did not change during the study years. The use of advanced therapies has increased among urban teaching, but not among urban non-teaching hospitals. During the study years, there was no change in unadjusted or adjusted in-hospital mortality rates among patients with acute PE, while the 90-day unplanned readmission rate has declined.
AB - There is a paucity of data regarding the contemporary temporal trends in the adoption of advanced pulmonary embolism (PE) therapies in the United States as well as the parallel trends in outcomes of patients with acute PE. Therefore, we queried the Nationwide Readmissions Database (years 2016-2020) to report the temporal trends in utilization of advanced PE therapies. Our final analysis included 920 770 hospitalizations with acute PE. We demonstrated an increase in the proportion of patients diagnosed with high-risk PE during the study years. Overall, there was an increase in the use of advanced PE therapies, which was mainly due to the increase in the utilization of systemic thrombolytics, and catheter-directed therapies. Also, extracorporeal membrane oxygenation cannulation showed an incremental increase over the study years. The use of inferior vena cava filter has declined, while the use of surgical embolectomy did not change during the study years. The use of advanced therapies has increased among urban teaching, but not among urban non-teaching hospitals. During the study years, there was no change in unadjusted or adjusted in-hospital mortality rates among patients with acute PE, while the 90-day unplanned readmission rate has declined.
KW - Acute pulmonary embolism
KW - Advanced therapies
KW - High-risk PE
KW - PERT
UR - http://www.scopus.com/inward/record.url?scp=85177074016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85177074016&partnerID=8YFLogxK
U2 - 10.1093/ehjacc/zuad092
DO - 10.1093/ehjacc/zuad092
M3 - Article
C2 - 37549064
AN - SCOPUS:85177074016
SN - 2048-8726
VL - 12
SP - 711
EP - 713
JO - European Heart Journal: Acute Cardiovascular Care
JF - European Heart Journal: Acute Cardiovascular Care
IS - 10
ER -